- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04943705
Evaluation of the Clinical Efficacy of Moxibustion With Regulating Yin and Yang in the Treatment of Menopausal Obesity
June 27, 2021 updated by: Hubei Hospital of Traditional Chinese Medicine
This study is designed as a two-dummy randomized controlled trial to evaluate the safety and superiority of Yin and Yang regulating moxibustion in the treatment of menopausal obese patients.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will be a multicenter, randomized, controlled trial, conducted from January 2021 to December 2022, including 216 menopausal obese patients who meet the inclusion criteria.
The subjects will be randomly divided into 2 treatment groups: Yin and Yang regulating moxibustion group and mild moxibustion group.
Each group of treatment will last for 12 weeks, with a follow-up period of 12 weeks.
The main outcome indicator is waist circumference.
The secondary outcome indicators include subjects related to obesity, TCM clinical syndrome score and modified Kupperman score, weight impact on quality of life scale (IWQOL-Lite), quality of life assessment health survey summary (SF-36).
During the intervention period, adverse events will be recorded.
Study Type
Interventional
Enrollment (Anticipated)
216
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhong-Yu Zhou, professor
- Phone Number: 86 18672308659
- Email: 2209447940@qq.com
Study Contact Backup
- Name: Wei Huang, professor
- Phone Number: 86 13986083982
- Email: huangwei@hbhtcm.com
Study Locations
-
-
-
Hubei, China
- Zhong-Yu Zhou
-
-
Hubei
-
Wuhan, Hubei, China, 430061
- Hubei Provincial Hospital of Traditional Chinese Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients who meet the diagnostic criteria for menopausal syndrome and obesity;
- Patients with BMI≥25 and waist circumference≥80cm;
- Female patients between 40-60 years old;
- Have not taken any hormone drugs or weight loss related drugs in the past 3 months;
- Sign the informed consent and voluntarily accept the intervention methods of this project.
Exclusion Criteria:
- Unexplained vaginal bleeding, or unnatural menopause;
- Have used hormone replacement therapy or other drugs related to this disease in the past 3 months;
- Combined with serious organic diseases, endocrine diseases, heart, liver and kidney, and respiratory diseases;
- Secondary obesity caused by hypothalamic lesions, hypothyroidism, glucocorticoid therapy, etc.;
- Combined with organic uterine diseases, such as polycystic ovary syndrome, malignant tumors, severe cervical erosion, after total hysterectomy, etc.;
- There are contraindications to moxibustion, such as moxibustion intolerance, skin allergies, scars, and other serious skin diseases;
- Poor compliance and unable to adhere to treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Yin and Yang Regulating Moxibustion
1.The acupoints will be selected as Shenque and Mingmen.The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Each treatment was 60min, once a week, Wenyang Yishen moxibustion and Peiyuan Guben moxibustion were performed alternately.
Each patient received WenYang Yishen moxibustion and then Peiyuan Guben moxibustion for a total of 12 weeks of treatment and 12 weeks of follow-up at the end of the treatment.
2.The diet and exercise control implementation plan is as follows:Participants weighed ≤113.6 kg (250 lbs) and had a prescription diet of 1200-1499 kcal/day, including traditional foods, of which protein was about 15-20 kcal, fat was about 20-35%, and the rest came from carbohydrates.
People weighing ≥113.6 kg are prescribed 1500-1800 kcal per day.
They were also instructed to continue moderate-intensity physical activities (such as jogging, brisk walking) at least 5 days a week, at least 210 minutes a week, preferably ≥270 minutes a week。
|
Before making Wenyang Yishen moxibustion, the width and length of the patient's moxibustion site were evaluated by the same body measurement method.
Take about 700g of fresh ground ginger with moderate dryness and wetness, and place it on the treatment towel to make a round cake with a diameter of about 20cm and a thickness of about 2.5cm.
Spread 25g of moxa moxa with a diameter of about 18cm on top of ginger and light it.
When the bottom temperature reaches about 37 degrees, the door can be placed on the patient's waist for treatment.
According to the patient's tolerance, the temperature should be controlled at 43-45 degrees.
It is better to replace the moxa biscuit every time when the moxa biscuit is burned for about 10 minutes.
The patient's local skin has a slight redness and burning.
The moxibustion time is 60 minutes.
Peiyuan Guben moxibustion is centered on Shenque, and the operation is the same as that of WenYang and Yishen moxibustion.
|
Active Comparator: Mild Moxibustion
1.The acupoints will be selected as Zhongwan, Guanyuan, Sanyinjiao (double).The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Light one end of the moxa stick and hang it about 2-3cm above the skin, taking the patient's local skin redness and conscious warmth as the degree.
Moxa-box moxibustion will be used for 20 minutes each treatment, once every other day, 3 times a week, for a total of 12 weeks of treatment, and 12 weeks of follow-up after the treatment.
2.Lifestyle modification:It will be performed as the same as the Yin and Yang Regulating Moxibustion group.
|
Before making Wenyang Yishen moxibustion, the width and length of the patient's moxibustion site were evaluated by the same body measurement method.
Take about 700g of fresh ground ginger with moderate dryness and wetness, and place it on the treatment towel to make a round cake with a diameter of about 20cm and a thickness of about 2.5cm.
Spread 25g of moxa moxa with a diameter of about 18cm on top of ginger and light it.
When the bottom temperature reaches about 37 degrees, the door can be placed on the patient's waist for treatment.
According to the patient's tolerance, the temperature should be controlled at 43-45 degrees.
It is better to replace the moxa biscuit every time when the moxa biscuit is burned for about 10 minutes.
The patient's local skin has a slight redness and burning.
The moxibustion time is 60 minutes.
Peiyuan Guben moxibustion is centered on Shenque, and the operation is the same as that of WenYang and Yishen moxibustion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Waist circumference
Time Frame: Week 0, 4, 8, 12, 18and24.
|
The change in waist circumference compared to the baseline.
|
Week 0, 4, 8, 12, 18and24.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMI(weight/height²)
Time Frame: Week 0, 4, 8, 12, 18and24.
|
BMI (weight/height²) will be measured.
|
Week 0, 4, 8, 12, 18and24.
|
Weight(WG)
Time Frame: Week 0, 4, 8, 12, 18and24.
|
Weight(WG) will be measured.
|
Week 0, 4, 8, 12, 18and24.
|
Hip circumference(HC)
Time Frame: Week 0, 4, 8, 12, 18and24.
|
Hip circumference(HC) will be measured.
|
Week 0, 4, 8, 12, 18and24.
|
Waist-to-hip ratio(waist circumference/hip circumference)
Time Frame: Week 0, 4, 8, 12, 18and24.
|
Waist-to-hip ratio(waist circumference/hip circumference) will be measured.
|
Week 0, 4, 8, 12, 18and24.
|
Body fat percentage(F percent)
Time Frame: Week 0, 4, 8, 12, 18and24.
|
Body fat percentage(F percent) will be measured.
|
Week 0, 4, 8, 12, 18and24.
|
The syndrome score of Traditional Chinese Medicine
Time Frame: Week 0, 12and24.
|
The syndrome score of Traditional Chinese Medicine will be adopted as the criterion of syndrome determination according to the diagnostic and therapeutic evaluation standard of simple obesity revised by the 5th National Obesity Research Conference in 1997.
The minimum value is 0#the maximum value is 30.
The lower the total score, the better of the outcome.
|
Week 0, 12and24.
|
The impact of weight on quality of life (IWQOL)-Lite scale
Time Frame: Week 0, 12and24.
|
The impact of weight on quality of life (IWQOL)- Lite scale will be measured.
The minimum value is 31#the maximum value is 155.
The lower the total score, the lighter the clinical symptoms of the patient.
|
Week 0, 12and24.
|
Modified Kupperman score
Time Frame: Week 0, 12and24.
|
The modified KMI score scale was used to evaluate the clinical symptoms of menopause before and after treatment.The minimum value is 0#the maximum value is 63.
The lower the total score, the lighter the clinical symptoms of the patient.
|
Week 0, 12and24.
|
The MOS Item Short from Health Survey(SF-36).
Time Frame: Week 0, 12and24.
|
This scale is a universal health-related quality of life scale.
The minimum value is 40#the maximum value is 147.The higher the comprehensive score, the better the quality of life.
|
Week 0, 12and24.
|
Blood lipids: cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C).
Time Frame: Week 0 and 12.
|
Compared with the baseline, the change value of this indicator.
|
Week 0 and 12.
|
Estrogen: estradiol (E2), serum follicle-forming hormone (FSH).
Time Frame: Week 0 and12.
|
Compared with the baseline, the change value of this indicator.
|
Week 0 and12.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Zhong-Yu Zhou, professor, Hubei Hospital of Traditional Chinese Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2021
Primary Completion (Anticipated)
December 30, 2021
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
June 13, 2021
First Submitted That Met QC Criteria
June 27, 2021
First Posted (Actual)
June 29, 2021
Study Record Updates
Last Update Posted (Actual)
June 29, 2021
Last Update Submitted That Met QC Criteria
June 27, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HubeiHTCM
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Yin and Yang Regulating Moxibustion
-
Beijing Ditan HospitalCompletedHepatocellular CarcinomaChina
-
Beijing Ditan HospitalActive, not recruiting
-
Shanghai University of Traditional Chinese MedicineMinistry of Science and Technology of the People´s Republic of ChinaUnknown
-
Beijing Ditan HospitalXiyuan Hospital of China Academy of Chinese Medical SciencesCompletedHepatocellular CarcinomaChina
-
Beijing Ditan HospitalRecruitingHepatocellular CarcinomaChina
-
University of Texas Southwestern Medical CenterCompletedBipolar Disorder | Substance Use DisorderUnited States
-
Prof. Lin ZhixiuRecruiting
-
The University of Hong KongNot yet recruitingCOVID19 | Herbal MedicineHong Kong
-
Shanghai Institute of Acupuncture, Moxibustion...Changhai Hospital; Fudan University; Shanghai Jiao Tong University School of... and other collaboratorsCompleted
-
Hubei Provincial Collaborative Innovation Center...UnknownAllergic Rhinitis | Patch,Chinese Herb | MoxibustionChina